In Jan 2016 shares were at $0.20. ...By October 2016, $3.96!The best time to buy SZLS is when the plateau is at its lowest... just like NOW! That's when the share price surges.
Summer doldrums are drawing to a close,
there's a new, wildly qualified, energised CFO,
covid resting revenues are rising with the travel boom,
the Care Oncology merger will be closed within two weeks,
Q2 financials will be released August 16th.
and Aristotle testing as part of the AVRT program will carve itself a huge share of the international oncology market!
Next step - include non-cancer disease diagnostics in Aristotle, such as; alzheimer's, congestive heart disease, and so many more!
In two years, SZLS will not be the same company! In five...wow!
The time is clearly now to get in!
GLTA!